4//SEC Filing
Triola Anna Diaz 4
Accession 0001104659-21-093949
CIK 0001724344other
Filed
Jul 19, 8:00 PM ET
Accepted
Jul 20, 4:06 PM ET
Size
5.6 KB
Accession
0001104659-21-093949
Insider Transaction Report
Form 4
Triola Anna Diaz
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-07-19+100,000→ 100,000 totalExercise: $2.49Exp: 2031-07-18→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to the option shall vest on July 19, 2022, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
Documents
Issuer
Entasis Therapeutics Holdings Inc.
CIK 0001724344
Entity typeother
Related Parties
1- filerCIK 0001873187
Filing Metadata
- Form type
- 4
- Filed
- Jul 19, 8:00 PM ET
- Accepted
- Jul 20, 4:06 PM ET
- Size
- 5.6 KB